Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
Clinical trial NCT06020885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06020885
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2025-10-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.